Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
Harrow (Nasdaq: HROW) will report third quarter 2025 financial results for the period ended September 30, 2025, on Monday, November 10, 2025 after market close. The company said it will post a Third Quarter Letter to Stockholders on its Investors page at harrow.com.
Harrow will host a conference call and live webcast at 8:00 a.m. ET on Tuesday, November 11, 2025 to discuss results and provide a business update. A replay will be available on the company website for one year. Telephone participants must register in advance to receive a unique dial-in and PIN.
Harrow (Nasdaq: HROW) terrà comunicati i risultati finanziari del terzo trimestre 2025 per il periodo terminato il 30 settembre 2025, lunedì 10 novembre 2025 dopo la chiusura del mercato. L'azienda ha dichiarato che pubblicherà una Lettera del Terzo Trimestre agli Azionisti sulla pagina Investitori di harrow.com.
Harrow ospiterà una conference call e una trasmissione in webcast in diretta alle 8:00 a.m. ET di martedì 11 novembre 2025 per discutere i risultati e fornire un aggiornamento sull'attività. Una replica sarà disponibile sul sito dell'azienda per un anno. I partecipanti telefonici devono registrarsi in anticipo per ricevere un numero di accesso e un PIN unici.
Harrow (Nasdaq: HROW) informará los resultados financieros del tercer trimestre de 2025 para el periodo terminado el 30 de septiembre de 2025, el lunes 10 de noviembre de 2025 tras el cierre del mercado. La empresa dijo que publicará una Carta del Tercer Trimestre a los Accionistas en su página de Inversionistas en harrow.com.
Harrow organizará una llamada de conferencia y una transmisión en vivo por webcast a las 8:00 a.m. ET del martes 11 de noviembre de 2025 para discutir los resultados y proporcionar una actualización comercial. Una repetición estará disponible en el sitio web de la empresa durante un año. Los participantes por teléfono deben registrarse con anticipación para recibir un número de marcación y un PIN únicos.
Harrow (Nasdaq: HROW)는 2025년 9월 30일로 종료된 기간의 2025년 3분기 재무 실적을 발표하며, 2025년 11월 10일 월요일 장 마감 후에 공개합니다. 회사는 harrow.com의 투자자 페이지에 제3분기 주주 서한을 게시할 것이라고 밝혔습니다.
Harrow는 2025년 11월 11일 화요일 동부 표준시 8:00에 컨퍼런스 콜과 라이브 웹캐스트를 개최하여 실적을 논의하고 비즈니스 업데이트를 제공합니다. 1년 동안 회사 웹사이트에서 재생(replay)을 이용할 수 있습니다. 전화 참가자는 고유한 다이얼인(dial-in)과 PIN을 받기 위해 사전에 등록해야 합니다.
Harrow (Nasdaq: HROW) annoncera les résultats financiers du troisième trimestre 2025 pour la période se terminant le 30 septembre 2025, le lundi 10 novembre 2025 après la clôture du marché. L'entreprise a indiqué qu'elle publierait une Lettre du troisième trimestre aux actionnaires sur sa page Investisseurs à harrow.com.
Harrow organisera une conférence téléphonique et une webdiffusion en direct à 8h00 HE le mardi 11 novembre 2025 pour discuter des résultats et fournir une mise à jour sur l'activité. Une rediffusion sera disponible sur le site de l'entreprise pendant un an. Les participants téléphoniques doivent s'inscrire à l'avance pour recevoir un numéro d'accès unique et un code PIN.
Harrow (Nasdaq: HROW) wird die Ergebnisse des dritten Quartals 2025 für den Zeitraum, der am 30. September 2025 endet, am Montag, dem 10. November 2025 nach Börsenschluss melden. Das Unternehmen gab bekannt, dass es einen Third Quarter Letter to Stockholders auf seiner Investorenseite unter harrow.com veröffentlichen wird.
Harrow wird am Dienstag, dem 11. November 2025 um 8:00 Uhr MEZ/ET eine Telefonkonferenz und einen Live-Webcast abhalten, um die Ergebnisse zu besprechen und ein Geschäftsupdate zu geben. Eine Wiedergabe wird für ein Jahr auf der Unternehmenswebsite verfügbar sein. Telefonteilnehmer müssen sich im Voraus registrieren, um eine eindeutige Einwahl (Dial-in) und PIN zu erhalten.
Harrow (Nasdaq: HROW) ستعلن عن نتائجها المالية للربع الثالث من 2025 للفترة المنتهية في 30 سبتمبر 2025، يوم الإثنين 10 نوفمبر 2025 بعد إغلاق السوق. قالت الشركة إنها ستنشر رسالة الربع الثالث إلى المساهمين في صفحة المستثمرين على harrow.com.
ستستضيف Harrow مكالمة مؤتمرات وبثًا مباشرًا عبر الويب في الساعة 8:00 صباحًا بتوقيت شرق الولايات المتحدة يوم الثلاثاء 11 نوفمبر 2025 لمناقشة النتائج وتقديم تحديث عن الأعمال. ستتوفر إعادة تشغيل للمكالمة على موقع الشركة لمدة عام. يجب على المشاركين عبر الهاتف التسجيل مسبقًا للحصول على رقم اتصال ورمز تعريف فريدين.
Harrow (Nasdaq: HROW) 将在2025年9月30日止的期间公布2025年第三季度财务业绩，时间为2025年11月10日（星期一）市场收盘后。公司表示将在 harrow.com 的投资者页面发布 Third Quarter Letter to Stockholders。
Harrow 将于2025年11月11日（星期二）美国东部时间上午 8:00 举行电话会议和现场网络广播，讨论业绩并提供业务更新。公司网站将提供为期一年的重播。电话参与者必须提前注册，以接收唯一的拨入号和 PIN。
- None.
- None.
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 11, 2025
NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial results for the third quarter ended September 30, 2025, on Monday, November 10, 2025, after the market close. The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Tuesday, November 11, 2025, to discuss the results and provide a business update.
Conference Call Information
Participants can access the live webcast of Harrow’s presentation on the “Investors” page of Harrow’s website. A replay of the webcast will be available on the Company’s website for one year.
To participate via telephone, please register in advance using this link. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com.
Contact:
Mike Biega
VP of Investor Relations & Communications
mbiega@harrowinc.com
617-913-8890
FAQ
When will Harrow (HROW) report Q3 2025 results?
What time is the Harrow (HROW) conference call to discuss Q3 2025 results?
Where can I find Harrow's (HROW) Third Quarter Letter to Stockholders for 2025?
How long will the Harrow (HROW) webcast replay be available?
How do I join Harrow's (HROW) Q3 2025 conference call by phone?
What will Harrow (HROW) cover on the Q3 2025 earnings call?
